Pîrlog, C., Costache, R., Paroșanu, A. I., Slavu, C. O., Olaru, M., Popa, A. M., . . . Nițipir, C. (2023). Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? MDPI AG.
Chicago Style (17th ed.) CitationPîrlog, Cristina-Florina, et al. Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? MDPI AG, 2023.
MLA (9th ed.) CitationPîrlog, Cristina-Florina, et al. Restricted Mean Survival Time—Can It Be a New Tool in Assessing the Survival of Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors? MDPI AG, 2023.
Warning: These citations may not always be 100% accurate.